Literature DB >> 12968287

Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency.

Phuong Lan Pham1, Sylvie Perret, Huyen Chau Doan, Brian Cass, Gilles St-Laurent, Amine Kamen, Yves Durocher.   

Abstract

Large-scale transient transfection of mammalian cells is a recent and powerful technology for the fast production of milligram amounts of recombinant proteins (r-proteins). As many r-proteins used for therapeutic and structural studies are naturally secreted or engineered to be secreted, a cost-effective serum-free culture medium that allows their efficient expression and purification is required. In an attempt to design such a serum-free medium, the effect of nine protein hydrolysates on cell proliferation, transfection efficiency, and volumetric productivity was evaluated using green fluorescent protein (GFP) and human placental secreted alkaline phosphate (SEAP) as reporter genes. The suspension growing, serum-free adapted HEK293SF-3F6 cell line was stably transfected with an EBNA1-expression vector to increase protein expression when using EBV oriP bearing plasmids. Compared to our standard serum-free medium, concomitant addition of the gelatin peptone N3 and removal of BSA slightly enhanced transfection efficiency and significantly increased volumetric productivity fourfold. Using the optimized medium formulation, transfection efficiencies between 40-60% were routinely obtained and SEAP production reached 18 mg/L(-1). To date, we have successfully produced and purified over fifteen r-proteins from 1-14-L bioreactors using this serum-free system. As examples, we describe the scale-up of two secreted his-tagged r-proteins Tie-2 and Neuropilin-1 extracellular domains (ED) in bioreactors. Each protein was successfully purified to >95% purity following a single immobilized metal affinity chromatography (IMAC) step. In contrast, purification of Tie-2 and Neuropilin-1 produced in serum-containing medium was much less efficient. Thus, the use of our new serum-free EBNA1 cell line with peptone-enriched serum-free medium significantly improves protein expression compared to peptone-less medium, and significantly increases their purification efficiency compared to serum-containing medium. This eliminates labor-intensive and expensive chromatographic steps, and allows for the simple, reliable, and extremely fast production of milligram amounts of r-proteins within 5 days posttransfection. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968287     DOI: 10.1002/bit.10774

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  31 in total

1.  Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors.

Authors:  Raj Haldankar; Danqing Li; Zane Saremi; Claudia Baikalov; Rohini Deshpande
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

2.  Development of a generic transient transfection process at 100 L scale.

Authors:  Ola Tuvesson; Christina Uhe; Aleksei Rozkov; Elke Lüllau
Journal:  Cytotechnology       Date:  2008-02-22       Impact factor: 2.058

3.  Laboratory Scale Production and Purification of a Therapeutic Antibody.

Authors:  Zehra Elgundi; Vicki Sifniotis; Mouhamad Reslan; Esteban Cruz; Veysel Kayser
Journal:  J Vis Exp       Date:  2017-01-24       Impact factor: 1.355

Review 4.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

5.  An anti-apoptotic HEK293 cell line provides a robust and high titer platform for transient protein expression in bioreactors.

Authors:  Tia A Arena; Bernice Chou; Peter D Harms; Athena W Wong
Journal:  MAbs       Date:  2019-04-24       Impact factor: 5.857

6.  Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.

Authors:  Matthew P Zustiak; Lisa Jose; Yueqing Xie; Jianwei Zhu; Michael J Betenbaugh
Journal:  Biotechnol J       Date:  2014-05-08       Impact factor: 4.677

7.  Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.

Authors:  Fatemeh Afkhami; Yves Durocher; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2010-10-14

8.  Monitoring of the effects of transfection with baculovirus on Sf9 cell line and expression of human dipeptidyl peptidase IV.

Authors:  Ozlem Ustün-Aytekin; Ismet Deliloğlu Gürhan; Kayoko Ohura; Teruko Imai; Gaye Ongen
Journal:  Cytotechnology       Date:  2013-05-29       Impact factor: 2.058

9.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

10.  Amplification of EBNA-1 through a single-plasmid vector-based gene amplification system in HEK293 cells as an efficient transient gene expression system.

Authors:  Sun-Hye Park; Jong-Ho Park; Joo-Hyoung Lee; Hoon-Min Lee; Yeon-Ju Kang; Eun-Ji Lee; Seunghyeon Shin; Gyun Min Lee; Yeon-Gu Kim
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.